New hope for advanced endometrial cancer: rucaparib maintenance studied
NCT ID NCT03617679
First seen Mar 06, 2026 · Last updated May 16, 2026 · Updated 10 times
Summary
This study tested whether the drug rucaparib can help keep metastatic or recurrent endometrial cancer from growing after initial chemotherapy. About 79 women with advanced disease who had already received 1-2 prior treatments were randomly assigned to receive either rucaparib or a placebo. The main goal was to see how long the cancer stayed under control before progressing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC ENDOMETRIAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Colorado Hospital
Aurora, Colorado, 80045, United States
Conditions
Explore the condition pages connected to this study.